CRB’s Horizons series of industry reports pools the talents and expertise of our leading subject matter experts to understand the conditions and forces affecting the life sciences and food and beverage industries. Based on hundreds of surveys of industry leaders, our free reports go deep on the critical trends driving the markets and how companies can stay on the leading edge.
HORIZONS
Download Now – Horizons: Life Sciences
Sign up now to be one of the first to receive our latest Horizons: Life Sciences report. With a focus on improved patient access, the report explores the similarities and differences between North America and Europe to examine the trends that will determine how quickly the next revolution in life-changing medicine will unfold.
Horizons: Market Conditions Q3 2023 report
As we approach the holiday season with a welcome recession-free outlook, the construction industry's workforce remains a challenging puzzle. Megaprojects in the manufacturing sector could cause additional labor and material shortages in the coming months and years.
Read More
Horizons: Life Sciences 2023 report
Our fourth Horizons: Life Sciences report focuses on the similarities and differences between North America and Europe to examine the trends that will determine how quickly the next revolution in life-changing medicine will unfold.
Read More
Horizons: Market Conditions Q2 2023 report
We’re midway through the year, and the global economy has surpassed expectations. As inflation and unemployment rates steadily decline, the Federal Reserve's pursuit of a soft landing appears increasingly promising.
Read More
Horizons: Market Conditions Q1 2023 report
The first installment of our quarterly Horizons: Market Conditions report finds capital project planning vexed by extreme uncertainty that permeates both the supply chain and labor pool, as rising interest rates and the expectation of a recession loom over the economy.
Read More
Horizons: Alternative Proteins 2023 report
This report explores the factors affecting the efficient and profitable scale-up of the alternative proteins market, covering everything from processing and operations to sustainability and regulations.
Read More
Horizons: Life Sciences 2022 report
This report explores an industry that is investing in novel research, pushing against long-established comfort zones, and moving cautiously but steadily toward an advanced standard of care for critically ill patients.
Read More
Horizons: Pet Food 2022 report
As consumers increasingly seek out high-quality, ethically-sourced, and sustainably-made pet food and treats, manufacturers must navigate new challenges and opportunities.
Read More
Horizons: Life Sciences 2021 report
We explore the disruptive forces reshaping how biopharma companies speed life-saving therapies and vaccines to the market.
Read More
Horizons: Alternative Proteins 2021 report
Growing demand for alternative proteins has manufacturers reconsidering everything from packaging and safety to regulation and project delivery.
Read More
Horizons: Cell & Gene Therapy 2020 report
Through a survey of nearly 150 industry leaders, our inaugural CRB Horizons: Cell and Gene Therapy report finds the biopharma space at a critical inflection point.
Read More
